2025-05-20-Jefferies-以色列化工集团（ICL）_第一季度业绩超预期；价格趋势持续改善；化肥基本面强劲_9页_156kb

ICL Summary: Q1 Performance, Outlook, and Valuation

Core Content

ICL is a global manufacturer of potash, phosphate, and bromine-related products. The company is the sixth-largest potash producer, holds a leading position in phosphoric acid, and accounts for one-third of global bromine derivative production. ICL is dual-listed on the Tel Aviv Stock Exchange (TASE) and the New York Stock Exchange (NYSE), with headquarters in Tel Aviv, Israel.

Q1 Performance

• Q1 EPS: $0.09, which was $0.01 above the analyst's estimate and in-line with consensus.
• Sales Growth: +2% YoY, driven by +5% volume growth, with price and FX effects contributing to a -1% and -2% impact respectively.
• Segment Performance:
  • Industrial Products: +3% sales (+5% volumes, -1% price, -1% FX)
  • Potash: -4% sales (+2% volumes, -5% price, -1% FX)
  • Phosphate Solutions: +3% sales (+5% volumes, -1% price, -1% FX)
  • Growing Solutions: +3% sales (+5% volumes, +3% price, -5% FX)

Near-Term Outlook

• Pricing Trends: Potash and phosphate pricing continue to improve, though the effects may be more noticeable in 2H25 due to contract lags.
• Market Conditions: Elevated interest rates and inflation are affecting customer purchasing habits, with automotive being the most vulnerable end-market.
• Demand Trends:
  • Bromine Derivatives: Cyclical demand is expected to turn in 2025.
  • Battery Materials: Demand for battery-grade phosphate is growing, with potential for $1 - 3%$ volume growth through 2026.
  • Growing Solutions: Positive outlook for Brazil 2025, strong North American trends, and growing Chinese biostimulant demand.
• FCF and M&A: Estimated cumulative post-dividend FCF of $600m in 2025E-2027E. M&A activity is likely to be the first use of cash, with a focus on technology in agriculture and sustainable solutions.
• Valuation Assumptions: At 10x EBITDA, and with 6% synergies, $500m in acquisitions could add $0.03-$0.05 to EPS.

Investment Thesis and Scenarios

Base Case

• Price Target: $7.00 (15.5x 2026E EPS)
• Rationale: Based on peer multiples and a blend of DCF, SOTP, and regression models.

Upside Scenario

• Price Target: $17.00 (159% increase)
• Rationale: Normalization in fertilizer demand, global recovery in construction and electronics markets, and a new cycle in deep-sea oil drilling.

Downside Scenario

• Price Target: $4.00 (-39% decrease)
• Rationale: Recession, loss of permits, S/D imbalances, adverse regulations, and insufficient FCF to cover dividends.

Key Catalysts

• Annual Potash Contract Settlements: With China and India, including shipping costs.
• Bromine Demand: Expected to improve.
• New Production Facilities: ICL signed an agreement to establish LFP production in Europe and commissioned a Battery Materials Innovation Center in the US.
• Acquisitions: ICL acquired Lavie Bio, an ag-biologicals company.
• Local Production: 60-70% of specialty sales in the US are produced locally.

Sustainability Matters

• Key Issues:
  • Product Design & Lifecycle Management: Optimizing crop yields and integrating precision ag tools.
  • Ecological Impacts: Regulatory focus on local ecosystems.
• Company Targets:
  • 35% reduction in absolute GHG emissions by 2035.
  • 35% reduction in GHG intensity by 2028.
  • Climate neutrality by 2050.
• Questions to Management:
  • Key innovation trends in Ag Tech that align with sustainability.
  • Impact of climate stress on production and value proposition.

Valuation and Risks

• Valuation Methodology: Includes market cap, growth/value, volatility, and expected total return over the next 12 months.
• Risks:
  • Loss of permits or mining concessions.
  • S/D imbalances in fertilizers.
  • Adverse regulations.
  • Reserve depletion.
  • Elongated innovation cycles.
  • Labor disputes.
  • Geopolitical events.
  • Poor M&A decisions.

Analyst Certification

All analysts certify that their views reflect their personal opinions and that no compensation is directly or indirectly related to the recommendations.

Investment Recommendation

• Rating: HOLD
• Price Target: $7.00 (+7% from current price of $6.57)
• Ratings Distribution:
  • BUY: 60.57%
  • HOLD: 35.08%
  • UNDERPERFORM: 4.35%

Important Disclosures

• Jefferies may have conflicts of interest due to business relationships with covered companies.
• The report is not tailored to individual investors and should be considered as one of many factors.
• Exchange rate fluctuations may affect non-US target prices.
• Research is distributed by various Jefferies entities depending on the jurisdiction.
• Jefferies may seek to do business with companies covered in this report, affecting objectivity.